These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 26568317

  • 1. Gastro-esophageal reflux and antisecretory drugs use among patients with chronic autoimmune atrophic gastritis: a study with pH-impedance monitoring.
    Tenca A, Massironi S, Pugliese D, Consonni D, Mauro A, Cavalcoli F, Franchina M, Spampatti M, Conte D, Penagini R.
    Neurogastroenterol Motil; 2016 Feb; 28(2):274-80. PubMed ID: 26568317
    [Abstract] [Full Text] [Related]

  • 2. Esophageal chemical clearance and baseline impedance values in patients with chronic autoimmune atrophic gastritis and gastro-esophageal reflux disease.
    Tenca A, de Bortoli N, Mauro A, Frazzoni M, Savarino E, Massironi S, Russo S, Bertani L, Marchi S, Penagini R.
    Dig Liver Dis; 2017 Sep; 49(9):978-983. PubMed ID: 28487082
    [Abstract] [Full Text] [Related]

  • 3. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring.
    Mainie I, Tutuian R, Shay S, Vela M, Zhang X, Sifrim D, Castell DO.
    Gut; 2006 Oct; 55(10):1398-402. PubMed ID: 16556669
    [Abstract] [Full Text] [Related]

  • 4. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N, Martinucci I, Savarino E, Bellini M, Bredenoord AJ, Franchi R, Bertani L, Furnari M, Savarino V, Blandizzi C, Marchi S.
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [Abstract] [Full Text] [Related]

  • 5. Prevalence, characteristics, and treatment outcomes of reflux hypersensitivity detected on pH-impedance monitoring.
    Patel A, Sayuk GS, Gyawali CP.
    Neurogastroenterol Motil; 2016 Sep; 28(9):1382-90. PubMed ID: 27061427
    [Abstract] [Full Text] [Related]

  • 6. Direct measurement of gastroesophageal reflux episodes in patients with squamous cell carcinoma by 24-h pH-impedance monitoring.
    Uno K, Iijima K, Hatta W, Koike T, Abe Y, Asano N, Kusaka G, Shimosegawa T.
    Am J Gastroenterol; 2011 Nov; 106(11):1923-9. PubMed ID: 21931379
    [Abstract] [Full Text] [Related]

  • 7. Combined esophageal multichannel intraluminal impedance and pH monitoring (MII -pH) in the diagnostics and treatment of gastroesophageal reflux disease and its complications.
    Masiak W, Wallner G, Wallner J, Pedowski T, Solecki M.
    Pol Przegl Chir; 2011 Sep; 83(9):488-96. PubMed ID: 22166737
    [Abstract] [Full Text] [Related]

  • 8. Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough.
    Ribolsi M, Savarino E, De Bortoli N, Balestrieri P, Furnari M, Martinucci I, Casale M, Greco F, Salvinelli F, Savarino V, Marchi S, Cicala M.
    Aliment Pharmacol Ther; 2014 Oct; 40(8):966-73. PubMed ID: 25109844
    [Abstract] [Full Text] [Related]

  • 9. Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux.
    Roman S, Keefer L, Imam H, Korrapati P, Mogni B, Eident K, Friesen L, Kahrilas PJ, Martinovich Z, Pandolfino JE.
    Neurogastroenterol Motil; 2015 Nov; 27(11):1667-74. PubMed ID: 26337396
    [Abstract] [Full Text] [Related]

  • 10. 24-hour pH-impedance monitoring on therapy to select patients with refractory reflux symptoms for antireflux surgery. A single center retrospective study.
    Desjardin M, Luc G, Collet D, Zerbib F.
    Neurogastroenterol Motil; 2016 Jan; 28(1):146-52. PubMed ID: 26526815
    [Abstract] [Full Text] [Related]

  • 11. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J, Kandulski A, Büsch F, Malfertheiner P.
    Dig Dis; 2009 Jan; 27(1):68-73. PubMed ID: 19439964
    [Abstract] [Full Text] [Related]

  • 12. A study with pharyngeal and esophageal 24-hour pH-impedance monitoring in patients with laryngopharyngeal symptoms refractory to proton pump inhibitors.
    Dulery C, Lechot A, Roman S, Bastier PL, Stoll D, de Gabory L, Zerbib F.
    Neurogastroenterol Motil; 2017 Jan; 29(1):. PubMed ID: 27424517
    [Abstract] [Full Text] [Related]

  • 13. Can acid (pH) refluxes predict multichannel intraluminal impedance refluxes? A correlation study.
    Misra S.
    J Gastroenterol Hepatol; 2010 Apr; 25(4):817-22. PubMed ID: 20492340
    [Abstract] [Full Text] [Related]

  • 14. Cough and gastroesophageal reflux: from the gastroenterologist end.
    Pauwels A, Blondeau K, Dupont L, Sifrim D.
    Pulm Pharmacol Ther; 2009 Apr; 22(2):135-8. PubMed ID: 19063984
    [Abstract] [Full Text] [Related]

  • 15. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ, Bredenoord AJ, Weusten BL, Monkelbaan JF, Timmer R, Smout AJ.
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [Abstract] [Full Text] [Related]

  • 16. High-dose esomeprazole for treatment of symptomatic refractory gastroesophageal reflux disease--a prospective pH-metry/impedance-controlled study.
    Bajbouj M, Becker V, Phillip V, Wilhelm D, Schmid RM, Meining A.
    Digestion; 2009 Oct; 80(2):112-8. PubMed ID: 19641320
    [Abstract] [Full Text] [Related]

  • 17. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
    Becker V, Bajbouj M, Waller K, Schmid RM, Meining A.
    Aliment Pharmacol Ther; 2007 Nov 15; 26(10):1355-60. PubMed ID: 17900268
    [Abstract] [Full Text] [Related]

  • 18. Objective Evidence of Gastro-Esophageal Reflux Disease is Rare in Patients with Autoimmune Gastritis.
    Pilotto V, Maddalo G, Orlando C, Fassan M, Rugge M, Farinati F, Savarino EV.
    J Gastrointestin Liver Dis; 2021 Mar 13; 30(1):30-36. PubMed ID: 33723550
    [Abstract] [Full Text] [Related]

  • 19. GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation.
    Patel A, Sayuk GS, Kushnir VM, Chan WW, Gyawali CP.
    Neurogastroenterol Motil; 2016 Apr 13; 28(4):513-21. PubMed ID: 26686239
    [Abstract] [Full Text] [Related]

  • 20. Increasing body weight enhances prevalence and proximal extent of reflux in GERD patients 'on' and 'off' PPI therapy.
    Blondeau K, Boecxstaens V, Van Oudenhove L, Farré R, Boeckxstaens G, Tack J.
    Neurogastroenterol Motil; 2011 Aug 13; 23(8):724-e327. PubMed ID: 21535319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.